APLS - Why Apellis Pharmaceuticals Stock Popped Today | Benzinga
Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) shares are trading higher Thursday after the company reported preliminary U.S. third-quarter net product revenue for SYFOVRE.
What To Know: Apellis highlighted continued strong demand for SYFOVRE, with preliminary U.S. revenue of approximately $74 million in the third-quarter.
Furthermore, approximately 37,000 commercial vials and 10,000 samples ...